Daniel Poeckel
Impact in
- Pharmacology top 2%
- Pharmacological Effects of Medicinal Plants
- Inflammatory mediators and NSAID effects
- Molecular Biology top 10%
- Bone Metabolism and Diseases
- Natural product bioactivities and synthesis
- Ubiquitin and proteasome pathways
Papers in
-
- Bone Metabolism and Diseases 6
- Natural product bioactivities and synthesis 2
- Peroxisome Proliferator-Activated Receptors 2
- Pharmacology 13
- Pharmacological Effects of Medicinal Plants 9
- Inflammatory mediators and NSAID effects 4
- Co-authors
- Oliver Werz (14 shared papers)Colin Funk (3 shared papers)Dieter Steinhilber (5 shared papers)Lars Tausch (6 shared papers)Johann Jauch (6 shared papers)Marcus Bantscheff (3 shared papers)Giovanna Bergamini (4 shared papers)Nico Zinn (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)British Journal of Pharmacology (2 papers)Planta Medica (2 papers)Biochemical Pharmacology (2 papers)Organic & Biomolecular Chemistry (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Daniel Poeckel
22 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Pharmacology 449
- Molecular Biology 656
- Biochemistry 69
- Biochemistry 44
- Immunology 146
Countries citing papers authored by Daniel Poeckel
This map shows the geographic impact of Daniel Poeckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Poeckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Poeckel more than expected).
Fields of papers citing papers by Daniel Poeckel
This network shows the impact of papers produced by Daniel Poeckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Poeckel. The network helps show where Daniel Poeckel may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Poeckel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 255 | |
| 2 | 2006 | 192 | |
| 3 | 2010 | 139 | |
| 4 | 2008 | 121 | |
| 5 | 2007 | 74 | |
| 6 | 2009 | 70 | |
| 7 | 2019 | 68 | |
| 8 | 2009 | 64 | |
| 9 | 2005 | 48 | |
| 10 | 2006 | 40 | |
| 11 | 2004 | 39 | |
| 12 | 2006 | 35 | |
| 13 | 2020 | 26 | |
| 14 | 2017 | 24 | |
| 15 | 2005 | 24 | |
| 16 | 2005 | 22 | |
| 17 | 2012 | 21 | |
| 18 | 2005 | 20 | |
| 19 | 2006 | 15 | |
| 20 | 2017 | 5 |
About Daniel Poeckel
Daniel Poeckel is a scholar working on Molecular Biology, Pharmacology, Immunology, Organic Chemistry and Cancer Research, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacological Effects of Medicinal Plants (9 papers), Bone Metabolism and Diseases (6 papers), Inflammatory mediators and NSAID effects (4 papers), Natural product bioactivities and synthesis (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), NF-κB Signaling Pathways (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). The work is most often cited by research in Pharmacology (449 citations), Molecular Biology (656 citations), Biochemistry (69 citations), Biochemistry (44 citations) and Immunology (146 citations). Daniel Poeckel has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Oliver Werz, Colin Funk, Dieter Steinhilber, Lars Tausch, Johann Jauch, Marcus Bantscheff, Giovanna Bergamini, Nico Zinn, Manfred Schubert‐Zsilavecz and Nils Kurzawa. Their work appears in journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology, Planta Medica, Biochemical Pharmacology and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.